King Misuzulu kaZwelithini has urged migrants to leave South Africa, echoing his late father's stance, following violent protests at a Durban primary school where immigration was blamed for admissions shortages.
Authorities in the Democratic Republic of Congo report a weekend drone attack on Kisangani's airport, marking a significant westward expansion of the conflict as M23 rebels are accused. No casualties were reported.
Brendan Banfield has been convicted of the aggravated murder of his wife and a stranger lured through a fake BDSM encounter, a plot allegedly orchestrated with the family's live-in nanny who testified against him.
A new global survey from JPMorgan Private Bank shows wealthy families remain overwhelmingly cautious on cryptocurrency investments, with a strong preference for traditional portfolio strategies despite market hype.
Universal Health Services (UHS) is drawing renewed investor interest following better-than-expected quarterly results, driven by robust behavioral health demand and a significant easing of industry-wide staffing pressures. While operational improvements bolster the near-term outlook, debates persist over valuation and the company's ability to sustain gains amid high debt levels.
Private equity firm RoundTable Healthcare Partners has acquired the dermatologist-trusted skincare and sun protection brand Colorescience from 1315 Capital, as the company's annual sales approach the $100 million mark.
As Wall Street remains fixated on software-based AI, a leading tech analyst argues the next trillion-dollar opportunity lies in 'physical AI'—machines that see, move, and act. Dan Ives of Wedbush singles out Tesla and Nvidia as the indispensable architects of this new industrial revolution.
Uber's vast trove of real-world driving data has become the cornerstone of a new autonomous vehicle partnership with Nvidia and Mercedes-Benz, potentially reshaping its investment narrative.
Major U.S. stock indices advanced Monday, setting a positive tone for a week packed with corporate earnings reports from technology giants and other bellwethers. Investor sentiment remains cautiously optimistic as early results surpass expectations.
As Uber Technologies prepares to report earnings, investors are weighing the long-term promise of its autonomous vehicle initiatives against immediate regulatory cost pressures in key markets like New York and France.
Rigetti Computing secures a significant order to deliver a 108-qubit quantum system to India's Centre for Development of Advanced Computing, marking a key commercial milestone and international expansion for the company amidst volatile stock performance.
Elon Musk is reportedly in advanced discussions to merge his space exploration giant, SpaceX, with his artificial intelligence venture, xAI, in a move that could reshape the frontiers of both industries and delay SpaceX's anticipated public offering.
In a rare show of common cause, both government supporters and opponents took to the streets of Caracas on Monday, demanding better salaries and pensions as the interim administration promises an oil-fueled recovery.
A former Starbucks executive alleges in a lawsuit that she was terminated after reporting maggot infestations and fire risks in new equipment, and refusing to falsify safety data.
Industry veteran Kristen Sosa joins Caleres as Division President, taking the helm of a portfolio including Stuart Weitzman, Veronica Beard, and Favorite Daughter, signaling a strategic push for growth.
The Texas-born travel center giant Buc-ee's is renowned for massive stores and spotless restrooms. But its most disruptive industry practice might be its pay scale, which far exceeds typical convenience store wages and fuels intense competition for jobs.
Opera's shares soared nearly 18% after the browser company integrated Tether's dominant USDT stablecoin into its MiniPay wallet, highlighting investor optimism around its Web3 strategy despite unanswered questions on long-term monetization.
In a strategic reshuffle following the exit of its product chief, Netflix has merged its product and technology divisions under veteran executive Elizabeth Stone, signaling a tighter integration of engineering and user experience.
New clinical imaging data for Molecular Partners' experimental radiotherapeutic MP0712, targeting the DLL3 protein in cancers like small cell lung cancer, show favorable tumor targeting and healthy organ clearance. The company confirms its U.S. Phase I/II trial is now open for patient screening.
Novo Nordisk launches its first oral GLP-1 weight-loss drug with strong early demand, reports positive Phase 3 results for CagriSema, and expands a cell therapy partnership for diabetes. These moves come as investors reevaluate the company's long-term growth prospects amid competitive and pricing pressures.
